特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
428064

マルチプレックス診断市場(技術(超高密度、高密度、中密度、低密度、次世代シーケンシング分析)、用途、最終利用者別) - 世界産業の分析、規模、構成比、成長率、動向および予測

Multiplexed Diagnostics Market (Technologies - Very High Density, High Density, Medium Density, Low Density, Next Generation Sequencing Assays; Applications; End Users) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

出版日: | 発行: Transparency Market Research | ページ情報: 英文 194 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
マルチプレックス診断市場(技術(超高密度、高密度、中密度、低密度、次世代シーケンシング分析)、用途、最終利用者別) - 世界産業の分析、規模、構成比、成長率、動向および予測
出版日: 2017年01月10日
発行: Transparency Market Research
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、マルチプレックス診断の世界市場に注目し、今後の推移を技術、用途、末端利用者および地域の別に予測するほか、産業構造、推進・抑制要因、機会、競合環境などの分析情報や主要参入企業のプロファイルをまとめています。

第1章 はじめに

  • 調査範囲と市場セグメンテーション
  • 調査ハイライト

第2章 前提と調査方法

  • 前提
  • 使用した略語
  • 調査方法

第3章 エグゼクティブサマリー

  • マルチプレックス診断の世界市場寸見

第4章 市場概要

  • 製品概要
  • 人口動態と市場指標
  • 重要産業イベント
  • マルチプレックス診断の世界市場規模(単位:100万米ドル)予測
  • マルチプレックス診断の世界市場展望
  • Porterのファイブフォース分析

第5章 市場動態

  • 推進・抑制要因の概略分析
  • 推進要因
  • 抑制要因
  • 機会
  • 機会分析

第6章 マルチプレックス診断の世界市場 - 技術別

  • イントロダクション
  • 重要所見
  • マルチプレックス診断の世界市場価額構成比 - 技術別
    • 超高密度マルチプレックス分析
    • 高密度マルチプレックス分析
    • 中密度
    • 低密度
    • 次世代シーケンシング分析
  • マルチプレックス診断の世界市場求心力分析 - 技術別
  • 重要動向

第7章 マルチプレックス診断の世界市場分析 - 用途別

  • イントロダクション
  • 重要所見
  • マルチプレックス診断の世界市場価額構成比 - 用途別
    • 感染性疾患診断
    • 腫瘍
    • 自己免疫疾患
    • 心疾患
    • アレルギー
    • その他(妊娠・受胎能試験ほか)
  • マルチプレックス診断市場求心力分析 - 用途別
  • 重要動向

第8章 マルチプレックス診断の世界市場分析 - 末端利用者別

  • イントロダクション
  • 重要所見
  • マルチプレックス診断の世界市場価額構成比 - 末端利用者別
    • 学術研究機関
    • 病院
    • 医薬品メーカー
    • 臨床研究機関
    • 診断ラボ
  • マルチプレックス診断市場求心力分析 - 末端利用者別
  • 重要動向

第9章 マルチプレックス診断の世界市場分析 - 地域別

  • 世界市場状況 - 地域別
  • マルチプレックス診断の世界市場価額構成比

第10章 北米のマルチプレックス診断市場分析

  • 重要所見
  • 市場概要
  • 北米のマルチプレックス診断市場価額構成比分析 - 国別
  • 北米のマルチプレックス診断市場価額構成比分析 - 技術別
  • 北米のマルチプレックス診断市場価額構成比分析 - 用途別
  • 北米のマルチプレックス診断市場価額構成比分析 - 末端利用者別
  • 北米のマルチプレックス診断市場求心力分析
  • 北米のマルチプレックス診断市場動向

第11章 欧州のマルチプレックス診断市場分析

  • 重要所見
  • 市場概要
  • 欧州のマルチプレックス診断市場価額構成比分析 - 国別
  • 欧州のマルチプレックス診断市場価額構成比分析 - 技術別
  • 欧州のマルチプレックス診断市場価額構成比分析 - 用途別
  • 欧州のマルチプレックス診断市場価額構成比分析 - 末端利用者別
  • 欧州のマルチプレックス診断市場求心力分析
  • 欧州のマルチプレックス診断市場動向

第12章 アジア太平洋地域のマルチプレックス診断市場分析

  • 重要所見
  • 市場概要
  • アジア太平洋地域のマルチプレックス診断市場価額構成比分析 - 国別
  • アジア太平洋地域のマルチプレックス診断市場価額構成比分析 - 技術別
  • アジア太平洋地域のマルチプレックス診断市場価額構成比分析 - 用途別
  • アジア太平洋地域のマルチプレックス診断市場価額構成比分析 - 末端利用者別
  • アジア太平洋地域のマルチプレックス診断市場求心力分析
  • アジア太平洋地域のマルチプレックス診断市場動向

第13章 中南米のマルチプレックス診断市場分析

  • 重要所見
  • 市場概要
  • 中南米のマルチプレックス診断市場価額構成比分析 - 国別
  • 中南米のマルチプレックス診断市場価額構成比分析 - 技術別
  • 中南米のマルチプレックス診断市場価額構成比分析 - 用途別
  • 中南米のマルチプレックス診断市場価額構成比分析 - 末端利用者別
  • 中南米のマルチプレックス診断市場求心力分析
  • 中南米のマルチプレックス診断市場動向

第14章 中東・アフリカのマルチプレックス診断市場分析

  • 重要所見
  • 市場概要
  • 中東・アフリカのマルチプレックス診断市場価額構成比分析 - 国別
  • 中東・アフリカのマルチプレックス診断市場価額構成比分析 - 技術別
  • 中東・アフリカのマルチプレックス診断市場価額構成比分析 - 用途別
  • 中東・アフリカのマルチプレックス診断市場価額構成比分析 - 末端利用者別
  • 中東・アフリカのマルチプレックス診断市場求心力分析
  • 中東・アフリカのマルチプレックス診断市場動向

第15章 競合環境

  • マルチプレックス診断の世界市場シェア - 企業別
  • 競合マトリクス
  • 企業プロファイル(企業の詳細、事業概要、財務、施策概要、SWOT分析)
目次

Global Multiplexed Diagnostics Market: Snapshot

The growth of private and public funding in the fields of genomics and personalized medicineis currently a high value driver for the global multiplexed diagnostics market. It is boosting the demand for advanced diagnostic technologies for precision-based diagnostics of life-threatening diseases. Current positive trends in the global multiplexed diagnostics market include the increasing rate of extensive research and development efforts being made to expand and diversify the existing applications in multiplexed diagnostics, the development in generic platforms, and a greater use of multiplexed diagnostics in academic and research organizations. However, the global multiplexed diagnostics market is being restrained by high costs pertaining to multiplexed diagnostics assay equipment and testing and an overall lack of skilled labor for handling the advanced equipment.

The global multiplexed diagnostics market was valued at US$5.0 bn in 2015. It is projected to reach US$26.36 bn by the end of 2024 after expanding at a CAGR of 20% from 2016 to 2024.

North America's Dominance in Global Multiplexed Diagnostics Market to Continue

The global Multiplexed diagnostics market is segmented on the basis of regions, into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2015, North America bagged for the leading share of the market in terms of value, owing to a rising prevalence of cardiac diseases and cancer in the region. North American players in the multiplexed diagnostics market also benefitted from the greater level of penetration of the national health care services. The region is expected to continue dominating the global multiplexed diagnostics market till 2024, a likelihood attributed to the region's high percentage of the geriatric population, an advanced and structured healthcare industry, and a large scope of application of reimbursement policies from both public and private sources.

In Europe, the market for multiplexed diagnostics is also expected to grow at a substantial rate with the growing involvement of academic and research institutes from Germany and the U.K. North America and Europe are projected to be highly lucrative markets for players from the global multiplexed diagnostics market. Conversely, multiplexed diagnostics have not yet found solid foundations in Latin America, Asia Pacific, and the Middle East & Africa to grow on for now.

image1

Infectious Disease Diagnostics in Full Swing

In terms of applications, the global multiplexed diagnostics market can be divided into autoimmune diseases, oncology, cardiac diseases, infectious disease diagnostic, and allergies. In 2015, a collective lead was attributed to the two segments of infectious disease diagnostics and oncology, due to an increase in the prevalence of infectious diseases along with a growing count of patients suffering from breast cancer, colorectal cancer, and prostate cancer. Oncology, cardiac diseases, and infectious disease diagnostics are expected to be highly beneficial segments for players from the global multiplexed diagnostics market. The segment for cardiac diseases is expected to expand at leading rate over the coming years due to the growing prevalence of various cardiovascular diseases. In terms of end users, the global multiplexed diagnostics market was led by academic research institutes in 2015. It is also expected to be the dominant end user in the market till 2024, owing to an increasing contribution of universities and cancer research centers and the research projects in the field of genetic engineering.

Till 2015, the leading players in the global multiplexed diagnostics market included Agilent Technologies, Bio-Rad Laboratories, Inc., BioMérieux SA, F. Hoffmann-La Roche Ltd., Illumina, Inc., Luminex Corporation, Hologic, Inc., Thermo Fisher Scientific, Inc., Siemens Healthineers, and Abbott Laboratories.

Report Description

Global Multiplexed Diagnostics Market: Overview

This report on the global multiplexed diagnostics market analyzes the current and future scenario of the global market. Rise in private and public funding for genomics and personalized medicine, rising demand for advanced diagnostic technology for accurate diagnosis of life-threatening diseases, and favorable regulatory scenario for new product launch are boosting the growth of the global multiplexed diagnostics market. Multiple Application of multiplexed diagnostics technology, and increasing prevalence of cancer and infectious diseases are some of the factors expected to drive the growth of global multiplexed diagnostics market during the forecast period.

The multiplexed diagnostics market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the global market with respect to the segments based on technology, application, end-user, and geography. A detailed qualitative analysis of drivers and restraints, and opportunities has been provided in the market overview section. Additionally, the section comprises porter's five forces analysis to help understand the competitive landscape in the market. This section also provides market attractiveness analysis in terms of geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global multiplexed diagnostics market.

Global Multiplexed Diagnostics Market: Scope of the Study

Based on technology type, the market has been segmented into Very high density multiplexed assays, High density multiplexed assays, Medium density multiplexed assays, Low density multiplexed assays, and Next generation sequencing assays. High density multiplexed assays and medium density multiplexed assays are projected to be lucrative segments of the multiplexed diagnostics market, due to increasing demand in academic research institutes and pharmaceutical companies. These segments are expected to grow at a highest CAGR rate during forecast period. The market segments have been analyzed based on cost-effectiveness of the technology, prevalence of the diseases, and growing demand for the diagnostic tools. The market size and forecast for each of these segments have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

Based on Application type, the Global multiplexed diagnostics market has been segmented into Infectious disease diagnostic, oncology, autoimmune diseases, cardiac diseases, allergies & others which include pregnancy & fertility testing. The market segments have been extensively analyzed based on increase in demand for the disease diagnostic and use in research activities, availability of the technology, and cost efficiency of each technology. Different types of end-users are present in the multiplexed diagnostics market. The end-users are Hospitals, pharmaceutical companies, clinical research organizations, and diagnostic laboratories. Under the end-user segment, the academic research institutes segment accounted for the largest share of the Global multiplexed diagnostics market in 2015 & is expected to dominate the market by 2024.

Global Multiplexed Diagnostics Market: Regional and Competitive Analysis

Geographically, the global Multiplexed Diagnostics Market has been categorized into five major regions and the key countries in the respective region: North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, Japan, China, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, Saudi Arabia, and Rest of Middle East & Africa).

The report also profiles major players in the Global multiplexed diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include Agilent Technologies, BioMérieux SA, Bio-Rad Laboratories, Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Luminex Corporation, Siemens Healthineers, Thermo Fisher Scientific, Inc., and Abbott Laboratories.

The global multiplexed diagnostics market has been segmented as given below:

Global Multiplexed Diagnostics Market, by Technology,

  • Very High Density Multiplexed Assays (> 10,000-plex)
  • High Density Multiplexed Assays (500 ≤ plex ≤ 10,000)
  • Medium Density Multiplexed Assays (plex < 500)
  • Low Density Multiplexed Assays (plex ≤ 5)
  • Next Generation Sequencing Assays

Global Multiplexed Diagnostics Market, by Application

  • Infectious Disease Diagnostic
  • Oncology
  • Autoimmune Diseases
  • Cardiac Diseases
  • Allergies
  • Others (pregnancy & fertility testing, etc.)

Global Multiplexed Diagnostics Market, by End User

  • Academic Research Institutes
  • Hospital
  • Pharmaceutical Companies
  • Clinical Research Organizations
  • Diagnostic Laboratories

Global Multiplexed Diagnostics Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights

2. Assumptions and Research Methodology

  • 2.1. Assumptions
  • 2.2. Acronyms Used
  • 2.3. Research Methodology

3. Executive Summary

  • 3.1. Global Multiplexed Diagnostics Market Snapshot

4. Market Overview

  • 4.1. Product Overview
  • 4.2. Demographics & Market Indicators
  • 4.3. Key Industry Events
  • 4.4. Global Multiplexed Diagnostics Market Size (US$ Mn) Forecast, 2014-2024
  • 4.5. Global Multiplexed Diagnostics Market Outlook
  • 4.6. Porter's Five Forces Analysis

5. Market Dynamics

  • 5.1. Drivers and Restraints Snapshot Analysis
  • 5.2. Drivers
    • 5.2.1. Growing demand for automated equipment and multifaceted analytical strategies
    • 5.2.2. Significant private and public funding for genomics and personalized medicine
    • 5.2.3. Rising demand for advanced diagnostic technology for accurate diagnosis of life-threatening diseases
    • 5.2.4. Increasing prevalence of cancer and infectious diseases
    • 5.2.5. Favorable regulatory scenario for new product launch
    • 5.2.6. Multiple Application of multiplexed diagnostics technology
  • 5.3. Restraints
    • 5.3.1. High cost associated with multiplexed diagnostics assay
    • 5.3.2. Lack of skilled labor
    • 5.3.3. High cost associated with multiplexed diagnostics assay
    • 5.3.4. Lack of skilled labor
  • 5.4. Opportunities
    • 5.4.1. Focus on extensive R&D to expand existing multiplexed diagnostics applications
    • 5.4.2. Development of generic platforms for multiplexed diagnostics
  • 5.5. Opportunity Analysis

6. Global Multiplexed Diagnostics Market Analysis, by Technology

  • 6.1. Introduction
  • 6.2. Key Findings
  • 6.3. Global Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2016-2024
    • 6.3.1. Very High Density Multiplexed Assays (> 10,000-plex)
    • 6.3.2. High Density Multiplexed Assays (500 ≤ plex ≤ 10,000)
    • 6.3.3. Medium Density Multiplexed Assays (plex < 500)
    • 6.3.4. Low Density Multiplexed Assays (plex ≤ 5)
    • 6.3.5. Next Generation Sequencing Assays
  • 6.4. Global Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2014-2024
  • 6.5. Key Trends

7. Global Multiplexed Diagnostics Market Analysis, by Application

  • 7.1. Introduction
  • 7.2. Key Findings
  • 7.3. Global Multiplexed Diagnostics Market Value Share Analysis, by Application, 2016 -2024
    • 7.3.1. Infectious Disease Diagnostic
    • 7.3.2. Oncology
    • 7.3.3. Autoimmune Diseases
    • 7.3.4. Cardiac Diseases
    • 7.3.5. Allergies
    • 7.3.6. Others (pregnancy & fertility testing, etc.)
  • 7.4. Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2014-2024
  • 7.5. Key Trends

8. Global Multiplexed Diagnostics Market Analysis, by End User

  • 8.1. Introduction
  • 8.2. Key Findings
  • 8.3. Global Multiplexed Diagnostics Market Value Share Analysis, by End-user 2016-2024
    • 8.3.1. Academic Research Institutes
    • 8.3.2. Hospitals
    • 8.3.3. Pharmaceutical Companies
    • 8.3.4. Clinical Research Organizations
    • 8.3.5. Diagnostic Laboratories
  • 8.4. Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2016-2024
  • 8.5. Key Trends

9. Global Multiplexed Diagnostics Market Analysis, by Region

  • 9.1. Global Market Scenario by Country
  • 9.2. Global Multiplexed Diagnostics Market Value Share Analysis, by Region, 2016 and 2024

10. North America Multiplexed Diagnostics Market Analysis

  • 10.1. Key Findings
  • 10.2. Market Overview
  • 10.3. North America Multiplexed Diagnostics Market Value Share Analysis, by Country
  • 10.4. North America Multiplexed Diagnostics Market Value Share Analysis, by Technology
  • 10.5. North America Multiplexed Diagnostics Market Value Share Analysis, by Application
  • 10.6. North America Multiplexed Diagnostics Market Value Share Analysis, by End User
  • 10.7. North America Multiplexed Diagnostics Market Attractiveness Analysis
  • 10.8. North America Multiplexed Diagnostics Market Trends

11. Europe Multiplexed Diagnostics Market Analysis

  • 11.1. Key Findings
  • 11.2. Market Overview
  • 11.3. Europe Multiplexed Diagnostics Market Value Share Analysis, by Country
  • 11.4. Europe Multiplexed Diagnostics Market Value Share Analysis, by Technology
  • 11.5. Europe Multiplexed Diagnostics Market Value Share Analysis, by Application
  • 11.6. Europe Multiplexed Diagnostics Market Value Share Analysis, by End User
  • 11.7. Europe Multiplexed Diagnostics Market Attractiveness Analysis
  • 11.8. Europe Multiplexed Diagnostics Market Trends

12. Asia Pacific Multiplexed Diagnostics Market Analysis

  • 12.1. Key Findings
  • 12.2. Market Overview
  • 12.3. Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by Country
  • 12.4. Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by Technology
  • 12.5. Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by Application
  • 12.6. Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by End User
  • 12.7. Asia Pacific Multiplexed Diagnostics Market Attractiveness Analysis
  • 12.8. Asia Pacific Multiplexed Diagnostics Market Trends

13. Latin America Multiplexed Diagnostics Market Analysis

  • 13.1. Key Findings
  • 13.2. Market Overview
  • 13.3. Latin America Multiplexed Diagnostics Market Value Share Analysis, by Country
  • 13.4. Latin America Multiplexed Diagnostics Market Value Share Analysis, by Technology
  • 13.5. Latin America Multiplexed Diagnostics Market Value Share Analysis, by Application
  • 13.6. Latin America Multiplexed Diagnostics Market Value Share Analysis, by End User
  • 13.7. Latin America Multiplexed Diagnostics Market Attractiveness Analysis
  • 13.8. Latin America Multiplexed Diagnostics Market Trends

14. Middle East & Africa Multiplexed Diagnostics Market Analysis

  • 14.1. Key Findings
  • 14.2. Market Overview
  • 14.3. Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by Country
  • 14.4. Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by Technology
  • 14.5. Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by Application
  • 14.6. Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by End User
  • 14.7. Middle East & Africa Multiplexed Diagnostics Market Attractiveness Analysis
  • 14.8. Middle East & Africa Multiplexed Diagnostics Market Trends

15. Competition Landscape

  • 15.1. Multiplexed Diagnostics Market Share Analysis By Company, 2015
  • 15.2. Competition Matrix
  • 15.3. Company Profiles
    • 15.3.1. Agilent Technologies
      • 15.3.1.1. Company Details
      • 15.3.1.2. Business Overview
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. Strategic Overview
      • 15.3.1.5. SWOT Analysis
    • 15.3.2. bioMérieux SA
      • 15.3.2.1. Company Details
      • 15.3.2.2. Business Overview
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. Strategic Overview
      • 15.3.2.5. SWOT Analysis
    • 15.3.3. Bio-Rad Laboratories, Inc.
      • 15.3.3.1. Company Details
      • 15.3.3.2. Business Overview
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. Strategic Overview
      • 15.3.3.5. SWOT Analysis
    • 15.3.4. Illumina, Inc.
      • 15.3.4.1. Company Details
      • 15.3.4.2. Business Overview
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. Strategic Overview
      • 15.3.4.5. SWOT Analysis
    • 15.3.5. F. Hoffmann-La Roche Ltd.
      • 15.3.5.1. Company Details
      • 15.3.5.2. Business Overview
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. Strategic Overview
      • 15.3.5.5. SWOT Analysis
    • 15.3.6. Hologic, Inc.
      • 15.3.6.1. Company Details
      • 15.3.6.2. Business Overview
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. Strategic Overview
      • 15.3.6.5. SWOT Analysis
    • 15.3.7. Luminex Corporation
      • 15.3.7.1. Company Details
      • 15.3.7.2. Business Overview
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. Strategic Overview
      • 15.3.7.5. SWOT Analysis
    • 15.3.8. Siemens Healthineers
      • 15.3.8.1. Company Details
      • 15.3.8.2. Business Overview
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. Strategic Overview
      • 15.3.8.5. SWOT Analysis
    • 15.3.9. Thermo Fisher Scientific, Inc.
      • 15.3.9.1. Company Details
      • 15.3.9.2. Business Overview
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. Strategic Overview
      • 15.3.9.5. SWOT Analysis
    • 15.3.10. Abbott Laboratories
      • 15.3.10.1. Company Details
      • 15.3.10.2. Business Overview
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. Strategic Overview
      • 15.3.10.5. SWOT Analysis

List of Figures

  • FIG. 1 Global Multiplexed Diagnostics Market Size (US$ Mn) Forecast, 2014-2024
  • FIG. 2 Multiplexed Diagnostics Market Value Share, by Application (2016)
  • FIG. 3 Multiplexed Diagnostics Market Value Share, by Region (2016)
  • FIG. 4 Multiplexed Diagnostics Market Value Share, by Technology (2016)
  • FIG. 5 Multiplexed Diagnostics Market Value Share, by End-user (2016)
  • FIG. 6 Global Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2016 and 2024
  • FIG. 7 Global Very High Density Multiplexed Assays (> 10,000-plex) Market Revenue (US$ Mn), 2014-2024
  • FIG. 8 Global High Density Multiplexed Assays (500 ≤ plex ≤ 10,000) Market Revenue (US$ Mn), 2014-2024
  • FIG. 9 Global Medium Density Multiplexed Assays (plex < 500) Market Revenue (US$ Mn), 2014-2024
  • FIG. 10 Global Low Density Multiplexed Assays (plex ≤ 5) Market Revenue (US$ Mn), 2014-2024
  • FIG. 11 Global Next Generation Sequencing Assays Market Revenue (US$ Mn), 2014-2024
  • FIG. 12 Multiplexed Diagnostics Market Attractiveness Analysis, by Technology , 2016-2024
  • FIG. 13 Global Multiplexed Diagnostics Market Value Share Analysis, by Application, 2016 and 2024
  • FIG. 14 Global Infectious Disease Diagnostic Market Revenue (US$ Mn), 2014-2024
  • FIG. 15 Global Oncology Market Revenue (US$ Mn), 2014-2024
  • FIG. 16 Global Infectious Disease Diagnostic Market Revenue (US$ Mn), 2014-2024
  • FIG. 17 Global Cardiac Diseases Market Revenue (US$ Mn), 2014-2024
  • FIG. 18 Global Allergies Market Revenue (US$ Mn), 2014-2024
  • FIG. 19 Global Others Market Revenue (US$ Mn), 2014-2024
  • FIG. 20 Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2014-2024
  • FIG. 21 Global Multiplexed Diagnostics Market Value Share Analysis, by End-user, 2016 and 2024
  • FIG. 22 Global Academic Research Institutes Market Revenue (US$ Mn), 2014-2024
  • FIG. 23 Global Hospitals Market Revenue (US$ Mn), 2014-2024
  • FIG. 24 Global Pharmaceutical Companies Market Revenue (US$ Mn), 2014-2024
  • FIG. 25 Global Clinical Research Organizations Market Revenue (US$ Mn), 2014-2024
  • FIG. 26 Global Diagnostic Laboratories Market Revenue (US$ Mn), 2014-2024
  • FIG. 27 Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2016-2024
  • FIG. 28 Global Multiplexed Diagnostics Market Value Share Analysis, by Region, 2016 and 2024
  • FIG. 29 Global Multiplexed Diagnostics Market Attractiveness Analysis, by Region, 2014-2024
  • FIG. 30 North America Multiplexed Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014-2024
  • FIG. 31 North America Multiplexed Diagnostics Market Attractiveness Analysis, by Country, 2016-2024
  • FIG. 32 North America Multiplexed Diagnostics Market Value Share Analysis, by Country, 2016 and 2024
  • FIG. 33 North America Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2016 and 2024
  • FIG. 34 North America Multiplexed Diagnostics Market Value Share Analysis, by Application, 2016 and 2024
  • FIG. 35 North America Multiplexed Diagnostics Market Value Share Analysis, by End User, 2016 and 2024
  • FIG. 36 North America Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2016-2024
  • FIG. 37 North America Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2016-2024
  • FIG. 38 North America Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2016-2024
  • FIG. 39 Europe Multiplexed Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014-2024
  • FIG. 40 Europe Multiplexed Diagnostics Market Attractiveness Analysis, by Country, 2016-2024
  • FIG. 41 Europe Multiplexed Diagnostics Market Value Share Analysis, by Country, 2016 and 2024
  • FIG. 42 Europe Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2016 and 2024
  • FIG. 43 Europe Multiplexed Diagnostics Market Value Share Analysis, by Application, 2016 and 2024
  • FIG. 44 Europe Multiplexed Diagnostics Market Value Share Analysis, by End-user, 2016 and 2024
  • FIG. 45 Europe Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2016-2024
  • FIG. 46 Europe Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2016-2024
  • FIG. 47 Europe Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2016-2024
  • FIG. 48 Asia Pacific Multiplexed Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014-2024
  • FIG. 49 Asia Pacific Multiplexed Diagnostics Market Attractiveness Analysis, by Country, 2016-2024
  • FIG. 50 Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by Country, 2016 and 2024
  • FIG. 51 Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2016 and 2024
  • FIG. 52 Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by Application, 2016 and 2024
  • FIG. 53 Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by End-user, 2016 and 2024
  • FIG. 54 Asia Pacific Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2016-2024
  • FIG. 55 Asia Pacific Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2016-2024
  • FIG. 56 Asia Pacific Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2016-2024
  • FIG. 57 Latin America Multiplexed Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014-2024
  • FIG. 58 Latin America Multiplexed Diagnostics Market Attractiveness Analysis, by Country, 2016-2024
  • FIG. 59 Latin America Multiplexed Diagnostics Market Value Share Analysis, by Country, 2016 and 2024
  • FIG. 60 Latin America Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2016 and 2024
  • FIG. 61 Latin America Multiplexed Diagnostics Market Value Share Analysis, by Application, 2016 and 2024
  • FIG. 62 Latin America Multiplexed Diagnostics Market Value Share Analysis, by End-user, 2016 and 2024
  • FIG. 63 Latin America Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2016-2024
  • FIG. 64 Latin America Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2016-2024
  • FIG. 65 Latin America Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2016-2024
  • FIG. 66 Middle East & Africa Multiplexed Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014-2024
  • FIG. 67 Middle East & Africa Multiplexed Diagnostics Market Attractiveness Analysis, by Country, 2016-2024
  • FIG. 68 Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by Country, 2016 and 2024
  • FIG. 69 Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2016 and 2024
  • FIG. 70 Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by Application, 2016 and 2024
  • FIG. 71 Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by End-user, 2016 and 2024
  • FIG. 72 Middle East & Africa Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2016-2024
  • FIG. 73 Middle East & Africa Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2016-2024
  • FIG. 74 Middle East & Africa Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2016-2024
  • FIG. 75 Global Multiplexed Diagnostics Market Share Analysis, by Company, 2016 (Estimated)

List of Tables

  • TABLE 1 Global Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2014-2024
  • TABLE 2 Global Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Application, 2014-2024
  • TABLE 3 Global Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2014-2024
  • TABLE 4 Global Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Region, 2014-2024
  • TABLE 5 North America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Country, 2014-2024
  • TABLE 6 North America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2014-2024
  • TABLE 7 North America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Application, 2014-2024
  • TABLE 8 North America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2014-2024
  • TABLE 9 Europe Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Country, 2014-2024
  • TABLE 10 Europe Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2014-2024
  • TABLE 11 Europe Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Application, 2014-2024
  • TABLE 12 Europe Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2014-2024
  • TABLE 13 Asia Pacific Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Country, 2014-2024
  • TABLE 14 Asia Pacific Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2014-2024
  • TABLE 15 Asia Pacific Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Application, 2014-2024
  • TABLE 16 Asia Pacific Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2014-2024
  • TABLE 17 Latin America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Country, 2014-2024
  • TABLE 18 Latin America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2014-2024
  • TABLE 19 Latin America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Application, 2014-2024
  • TABLE 20 Latin America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2014-2024
  • TABLE 21 Middle East & Africa Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Country, 2014-2024
  • TABLE 22 Middle East & Africa Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2014-2024
  • TABLE 23 Middle East & Africa Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Application, 2014-2024
  • TABLE 24 Middle East & Africa Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2014-2024
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.